Gerard L. Coté is director of the TEES Center for Remote Health Technologies and Systems (CRHTS) and holds the Charles H. & Bettye Barclay Professorship in the Department of Biomedical Engineering at Texas A&M University. He is recognized as a world-wide expert in optical sensing for diagnostic and biomedical monitoring applications. Specifically, his research focuses on the development of macro-scale to nano-scale systems using lasers, optics and electronics for in vivo and in vitro sensing, such as development of a glucose-monitoring system for determining blood sugar levels in patients with diabetes; optically monitoring perfusion and oxygenation for tissue transplants and wearable technologies; and development of point-of-care and cell phone-based devices to remotely detect cardiac biomarkers, blood toxins, skin cancer and malaria. He has coauthored more than 300 publications, proceedings and abstracts, and he has received funding from the National Institutes of Health, the National Science Foundation and private industry. Dr. Coté also contributes to translational research and the innovation ecosystem as the co-holder of several U.S. patents and as a co-founder of three medical device companies namely; BioTex, BasePairBioTechnologies, and Visualase (recently acquired by Medtronic). Dr. Coté is a Fellow of four societies including the Institute of Electrical and Electronics Engineers, the American Institute for Medical and Biological Engineering, the Biomedical Engineering Society, and the international Society for Optics and Photonics.
Ph.D., Bioengineering, University of Connecticut, Storrs
M.S., Bioengineering, University of Connecticut, Storrs
B.S., Electrical Engineering, Rochester Institute of Technology